These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 29217104)
21. How beneficial and safe is tocilizumab for patients with giant cell arteritis? A Cochrane Review summary with commentary. Coskun Benlidayi I Int J Rheum Dis; 2022 Aug; 25(8):945-949. PubMed ID: 35796249 [No Abstract] [Full Text] [Related]
22. Treatment failure in giant cell arteritis. Unizony SH; Bao M; Han J; Luder Y; Pavlov A; Stone JH Ann Rheum Dis; 2021 Nov; 80(11):1467-1474. PubMed ID: 34049857 [TBL] [Abstract][Full Text] [Related]
24. Outcomes of giant cell arteritis patients treated with tocilizumab in a single neuro-ophthalmology practice. Fong JW; Sharieff JA; Patel AD Can J Ophthalmol; 2023 Apr; 58(2):e61-e62. PubMed ID: 36126697 [No Abstract] [Full Text] [Related]
27. Reply to Should Tocilizumab Be Used Routinely in New Patients With a Diagnosis of Giant Cell Arteritis? Gordon LK; Sadun AA; Van Stavern G; Lee AG J Neuroophthalmol; 2022 Jun; 42(2):e535-e536. PubMed ID: 35594160 [No Abstract] [Full Text] [Related]
28. Tocilizumab-induced sarcoidosis-like reaction in a patient with giant cell arteritis. Clinical implications of a paradoxical phenomenon. Theodosiou G; Luu H; Svensson Å Int J Dermatol; 2020 Jul; 59(7):888-889. PubMed ID: 32358964 [No Abstract] [Full Text] [Related]
29. Tocilizumab in the treatment of giant cell arteritis. Leuchten N; Aringer M Immunotherapy; 2018 Mar; 10(6):465-472. PubMed ID: 29504436 [TBL] [Abstract][Full Text] [Related]
30. Tocilizumab in giant cell arteritis: an update for the clinician. Ford JA; Gewurz D; Gewurz-Singer O Curr Opin Rheumatol; 2023 May; 35(3):135-140. PubMed ID: 36912060 [TBL] [Abstract][Full Text] [Related]
32. Tocilizumab as an add-on therapy to glucocorticoids during the first 3 months of treatment of Giant cell arteritis: A prospective study. Samson M; Devilliers H; Ly KH; Maurier F; Bienvenu B; Terrier B; Charles P; Guillevin L; Besancenot JF; Liozon E; Fauchais AL; Loffroy R; Binquet C; Audia S; Seror R; Mariette X; Bonnotte B Eur J Intern Med; 2018 Nov; 57():96-104. PubMed ID: 30054122 [TBL] [Abstract][Full Text] [Related]
33. Tocilizumab for Giant Cell Arteritis-A New Giant Step in an Old Disease. Tamaki H; Hajj-Ali RA JAMA Neurol; 2018 Feb; 75(2):145-146. PubMed ID: 29255889 [No Abstract] [Full Text] [Related]
34. [Treatment of giant cell arteritis]. Samson M; Greigert H; Ghesquière T; Bonnotte B Presse Med; 2019 Sep; 48(9):968-979. PubMed ID: 31324351 [TBL] [Abstract][Full Text] [Related]
35. Interleukin-6 flags infection in tocilizumab-treated giant cell arteritis. Berger CT; Recher M; Daikeler T Rheumatology (Oxford); 2018 Jan; 57(1):196-197. PubMed ID: 28968856 [No Abstract] [Full Text] [Related]
36. The Role of Tocilizumab in Glucocorticoid Resistant Giant Cell Arteritis: A Case Series and Literature Review. Stretton B; Tan Y; Hassall M; Simon S J Neuroophthalmol; 2023 Mar; 43(1):91-95. PubMed ID: 36166708 [TBL] [Abstract][Full Text] [Related]
37. Successful use of ixekizumab for glucocorticoid-free remission maintenance in giant cell arteritis. Tomelleri A; Rinaldi E; Campochiaro C; Picchio M; Dagna L Rheumatology (Oxford); 2023 Feb; 62(2):e24-e26. PubMed ID: 35861513 [No Abstract] [Full Text] [Related]
38. [Treatment of giant cell arteritis: what is in the pipeline?]. Holle JU; Moosig F Z Rheumatol; 2020 Aug; 79(6):516-522. PubMed ID: 32399619 [TBL] [Abstract][Full Text] [Related]
39. A severe cerebral infarction associated with giant cell arteritis, which developed during tocilizumab therapy and was successfully treated with intravenous cyclophosphamide. Suzuki K; Akiyama M; Ishigaki S; Kondo Y; Saito S; Kikuchi J; Hanaoka H; Kaneko Y Mod Rheumatol Case Rep; 2023 Jun; 7(2):453-457. PubMed ID: 36715093 [TBL] [Abstract][Full Text] [Related]
40. A multicentre, large-scale, observational study of tocilizumab in patients with giant cell arteritis in Japan. Harigai M; Miyamae T; Hashimoto H; Umetsu K; Yamashita K; Nakaoka Y Mod Rheumatol; 2024 Jul; 34(4):775-783. PubMed ID: 37522620 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]